StockData
IceCure Medical Ltd. logo

IceCure Medical Ltd. (ICCM) shareholders

ICCMNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Số liệu tài chính tới năm tài chính 2025, năm kết thúc ngày Dec 31, 2025Last filing: 20-F on Mar 17, 2026Score 2/30
$0.83+0.07 (+9.21%)

Close on Nov 17, 2026Market cap $2.84MP/E 0.1Yield –

Ownership

Institutional holdings as of Jun 30, 2026, from 13F filings

Held by institutions
0.2%
0M of 73M shares
Institutional holders
11
2 new, 9 sold out
Net institutional buying
0M
In Q2 2026
Insider trades, 12 months
0 buys · 0 sales
Open-market trades only

Shares held by institutions

Holders of more than 5%

Latest Schedule 13D (active) or 13G (passive) filed by each holder

HolderShares% of classFilingAs of
Mr. Li Haixiang
Joint filing with Epoch Partner Investments Limited (45.80%)
35,846,59745.80%13D (active) amendmentMar 17, 2026
Epoch Partner Investments Limited25,846,59752.20%13G (passive) amendmentSep 30, 2024
Armistice Capital, LLC
Joint filing with Steven Boyd (9.99%)
300,3329.99%13G (passive)Jun 30, 2026

Top institutional holders

13F holdings as of Jun 30, 2026

HolderShares% of ICCMValueChange% of portfolio
Jane Street Group, LLC34,8850.05%$169.54KNew0.00%
Scientech Research LLC32,6960.04%$158.90KNew0.13%
Gunderson Capital Management Inc.20,0000.03%$3.03K+19,3330.00%
UBS Group AG17,0930.02%$83.07K+11,9540.00%
Hrt Financial LP15,1510.02%$73.00K+13,5640.00%
JPMorgan Chase & Co5,9500.01%$31.30K+5,7520.00%
Morgan Stanley4,3340.01%$21.06K+3,7670.00%
Kingdom Financial Group LLC.5330.00%$2.59K–0.00%
SBI Securities Co., Ltd.4510.00%$2.19K+4510.00%
Avion Wealth1950.00%$0–0.00%
Bartlett & Co. Wealth Management LLC80.00%$39–0.00%

Institutional buying and selling by quarter

Positions opened, added to, reduced and closed by 13F filers

QuarterHoldersShares held% of sharesNew / addedReduced / closedShares boughtShares sold
Q2 2026110M0.2%2 / 60 / 90M0M
Q1 2026180M0.1%5 / 30 / 60M0M
Q4 2025190M0.0%5 / 23 / 30M0M
Q3 2025170M0.0%1 / 82 / 20M0M
Q2 2025180M0.0%6 / 40 / 20M0M
Q1 2025140M0.0%4 / 02 / 30M0M
Q4 2024130M0.0%3 / 22 / 50M0M
Q3 2024150M0.0%4 / 02 / 30M0M
Q2 2024140M0.0%5 / 21 / 30M0M
Q1 2024120M0.0%4 / 22 / 90M0M
Q4 2023170M0.0%7 / 33 / 20M0M
Q3 2023120M0.0%5 / 32 / 50M0M

Officers, directors and major owners

People who filed Forms 3, 4 or 5 in the last two years

NameRoleShares owned% of sharesLatest filing
Eyal ShamirChief Executive Officer, Director431,2810.59%Nov 2, 2026
Shad GoodVP, Sales for North America136,6980.19%Aug 17, 2026
Shay LevavChief Operating Officer146,3030.20%Aug 17, 2026
Tlalit Bussi Tel-TzureVP, BD & Global Marketing106,5180.15%Aug 17, 2026
Meir PelegChief Financial Officer194,8160.27%Aug 17, 2026
Merav Nir DotanVP, Human Resources76,1680.10%Aug 17, 2026
Naum MuchnikVP, R&D & Engineering118,6210.16%May 18, 2026
Ronen TsimermanChief Financial Officer177,9490.24%May 18, 2026
Ron MayronDirector176,4640.24%Nov 2, 2026
David SaltonDirector––Aug 17, 2026
Vincent Chun Hung ChanDirector––Aug 17, 2026
Sharon LevitaDirector––Mar 25, 2026
Yonatan MalcaDirector––Mar 25, 2026
Yang HuangDirector111,4680.15%Mar 25, 2026

Insider trades

Common stock transactions reported on Form 4, newest first

InsiderDateTransactionSharesPriceValueShares after
Eyal Shamir
Chief Executive Officer, Director
Nov 2, 2026Award+404,901––431,281
Ron Mayron
Director
Nov 2, 2026Award+166,577––176,464
Meir Peleg
Chief Financial Officer
Aug 14, 2026Award+181,483––194,816
Tlalit Bussi Tel-Tzure
VP, BD & Global Marketing
Aug 14, 2026Award+101,483––106,518
Shay Levav
Chief Operating Officer
Aug 14, 2026Award+141,483––146,303
Shad Good
VP, Sales for North America
Aug 14, 2026Award+131,483––136,698
Merav Nir Dotan
VP, Human Resources
Aug 14, 2026Award+73,890––76,168

Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.

Short interest

Shares sold short and not yet bought back, as of Oct 30, 2026 (FINRA, reported twice a month)

Short % of shares outstanding
1.64%
0M shares short
Days to cover
1.0
At 0M shares a day
Change since last report
+33.1%
From 0M shares
Short volume, 20 days
42.0%
Of volume reported to FINRA

Shares sold short, last 12 months

Short sale volume counts trades marked short on any given day, including market-maker hedging, so it runs far higher than the share of IceCure Medical's stock actually held short. Settlement fails (shares not delivered on time) peaked at 9,282 shares on Oct 1, 2026 over the last 90 days.

See a number that looks wrong?